Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-030181

Director bought 7,000 shares at $44.85 ($313,948)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Greene John Director 2025-02-26 Purchase +7,000 $44.85 $313,948 7,000 D: show line 1 in the form
Open-market purchases · 7,000 sh · avg $44.85 · $313,948
Loading xslF345X05/ownership.xml…